Related Experiment Video
Updated: Apr 21, 2026

Comprehensive & Cost Effective Laboratory Monitoring of HIV/AIDS: an African Role Model
Published on: October 31, 2010
Cancer screening and prevention in low-resource settings
Aditi Shastri1, Surendra Srinivas Shastri2
1Albert Einstein College of Medicine, Hematology-Oncology, 1300 Morris Park Avenue, Bronx, New York, New York 10461, USA.
Cancer incidence is rising in less-developed countries (LDCs) due to lifestyle changes and aging populations. Sustainable, cost-effective prevention and screening are crucial for these nations to combat high cancer mortality rates.
Area of Science:
- Public Health
- Oncology
- Global Health
Background:
- Less-developed countries (LDCs) face a growing cancer burden.
- Rising incidence linked to lifestyle shifts, infections, carcinogens, and increased longevity.
- Limited resources in LDCs exacerbate high cancer mortality rates.
Purpose of the Study:
- To outline the burden of preventable cancers in selected LDCs.
- To discuss evidence on cost-effective prevention and screening strategies.
- To advocate for nationally implementable and sustainable cancer control.
Main Methods:
- Review of cancer incidence data in selected LDCs.
- Analysis of existing literature on cancer prevention and screening.
- Assessment of cost-effectiveness and implementability of strategies.
Main Results:
- Significant burden of preventable cancers identified in LDCs.
- Evidence supports cost-effective prevention and screening interventions.
- Strategies need to be tailored for national implementation and sustainability.
Conclusions:
- Prioritizing prevention and screening is essential for LDCs.
- Sustainable, cost-effective approaches can reduce cancer mortality.
- Investment in national cancer control plans is critical for LDCs.
More Related Videos
Related Concept Videos
Preventive Healthcare Services
Cancer Prevention
Cancer Prevention
Some...
Levels of Health Promotion and Illness Prevention
In primary prevention, actions taken before disease onset prevent the disease from...
Cancer Survival Analysis
Cancer-Critical Genes II: Tumor Suppressor Genes

